King Pharma Income Statement Analysis for September 2009 Quarter
SeekingAlpha.com (Free subscription) | 13 hours ago
Neil Carvin submits: King Pharmaceuticals, Inc. (NYSE: KG ) earned $0.17 per share in the third quarter of 2009, down from $0.34 in the same quarter of last year. On a non - GAAP (" pro forma " or "ex-items") basis, earnings fell from $0.39 to $0.29 per share. The pretax difference between GAAP and non-GAAP Net Income was $46 million in the latest quarter. The most substantial...



